Back to Faculty & Staff

Jerome C. Landry, M.D.
Chief of Service, Grady Memorial Hospital
Professor

Education and Degrees

  • M.B.A., Kennesaw State University, Kennesaw, Georgia, 1998
  • M.D., Harvard Medical School, Boston, Massachusetts, 1983
  • B.S., Xavier University, New Orleans, Louisiana, 1978

Certification

  • American Board of Radiology, Therapeutic Radiology, 1988

Training

  • Residency in Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, 1984-7
  • Internship in Internal Medicine, Emory University Hospital, Atlanta, Georgia, 1983-4

Special Interests

  • Gastrointestinal malignancies
  • Sarcomas
  • Intensity-Modulated Radiation Therapy

Achievements and Honors

  • Voted one of the Best Doctors in America, 1995, 1997-8, 2000

Committee Memberships

  • Radiation Therapy Oncology Group, Gastrointestinal Committee, 1994-Present
  • Eastern Cooperative Oncology Group, Gastrointestinal Committee, 1995-Present
  • American Board of Radiology, Examiner, 2000-1
  • American Board of Radiology, Guest Examiner, 1995-Present
  • Patterns of Care Committee for Gastrointestinal Oncology, 1995-Present
  • Food and Drug Administration, Radiological Devices Patent Committee, 1998-Present

Selected Recent Publications

  • Koshy M, Esiashvili N, Landry JC, Thomas CR Jr, Matthews RH.  Multiple management modalities in esophageal cancer:  combined modality management approaches.  The Oncologist 9(2): 147-59; 2004.

  • Koshy M, Esiashvili N, Landry JC, Thomas CR Jr, Matthews RH.  Multiple management modalities in esophageal cancer:  epidemiology, presentation and progression, work-up, and surgical approaches.  The Oncologist 9(2): 137-46; 2004.

  • Esiashvili N, Koshy M, Landy J.  Intensity-modulated radiation therapy.  Current Problems in Cancer 28(2): 47-84; 2004.

  • Koshy M, Landry JC, Lawson JD, Esiashvili N, Staley CA, Howell R, Ting JY, Davis LW.  Potential for toxicity reduction using intensity modulated radiation therapy (IMRT) for retroperitoneal sarcoma.  International Journal of Radiation Oncology Biology Physics 57(2 Suppl):  S448-9; 2003.

  • Landry JC, Rosenthal D, Spitz F, Haller D, Benson A, Sigurdson E, Castelano P.  ECOG 1297: a phase I study of preoperative radiation therapy (RT) with concurrent protracted continuous infusion 5-FU and dose escalating oxaliplatin followed by surgery, adjuvant 5-FU, and leucovorin for locally advanced (T3/4) rectal adenocarcinoma.  International Journal of Radiation Oncology Biology Physics 57(2 Suppl): S179; 2003.

  • Burri SH, Landry JC, Davis LW.  Breast conservation is an effective option in Black, medically indigent patients.  Journal of the National Medical Association 94(6): 453-8; 2002.

  • Esiashvili N, Landry J, Matthews RH.  Carcinoma of the anus:  strategies in management. The Oncologist 7(3):  188-99; 2002.

  • Landry J, et al.  Cutting edge clinical practice:  pancreatic cancer.  Oncology Roundtable 1: 24-7; 2002.

  • Landry J, Coia LR, et al.  Outcome of patients receiving radiation for cancer of the esophagus:  results of the 1992-1994 patterns of care study.  Classic Papers and Current Comments 6(4): 742-50; 2002. 

  • Landry JC, Yang GY, Ting JY, Staley CA, Torres W, Esiashvili N, Davis LW.  Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.  Medical Dosimetry 27(2): 121-9; 2002.

  • Willet C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P.  Radiation Therapy Oncology Group Research Plan 2002-2006:  Gastrointestinal Cancer Committee.  International Journal of Radiation Oncology Biology Physics 51(3 Suppl 2): 19-27; 2001.

  • Landry JC, Yang GY.  Neoadjuvant therapy for rectal cancer. Colorectal  Cancer: Index and Reviews 1(3): 3-7; 2000.

  • Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE.  Outcome of patients receiving radiation for cancer of the esophagus:  results of the 1992-1994 patterns of care study.  Journal of Clinical Oncology 18: 455-62; 2000.

  • Willett CG, Landry JC, Machuta S.   Local excision with or without radiation in T1 and T2 rectal tumors. Annals of Surgery 230(1): 49-54; 1999. 

  • Bhalla K, Landry JC, Harris WB, Daneker G, Myers M, Staley C.  Phase I study of gemcitabine, cisplatin, 5-fluorouracil and leucovorin with G-CSF support in pancreatic and other gastrointestinal  cancers:  a preliminary report. Cancer Investigations 17(1): 26-30; 1999. 

  • Coia LR, Minsky BD, Madhu JJ, Haller DG, Landry J, Pisansky TM, Willet CG, Hoffman JP, Berkey BA, Owen JB, Hanks GE.  The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus.  Cancer 85(12):  2499-505; 1999.